Change in daytime sleepiness and cognitive function in a 6-month, double-blind study of lurasidone and quetiapine XR in patients with schizophrenia

por Harvey, Philip D., Siu, Cynthia O., Loebel, Antony D.
Publicado 2016

Sleep Disturbance, Irritability, and Response to Lurasidone Treatment in Children and Adolescents with Bipolar Depression

por Singh, Manpreet K., Siu, Cynthia, Tocco, Michael, Pikalov, Andrei, Loebel, Antony
Publicado 2023

Lurasidone in Children and Adolescents with Bipolar Depression Presenting with Mixed (Subsyndromal Hypomanic) Features: Post Hoc Analysis of a Randomized Placebo-Controlled Trial

por Singh, Manpreet K., Pikalov, Andrei, Siu, Cynthia, Tocco, Michael, Loebel, Antony
Publicado 2020

F121. DOES RELAPSE CONTRIBUTE TO TREATMENT RESISTANCE? ANTIPSYCHOTIC RESPONSE IN FIRST- VS. SECOND-EPISODE SCHIZOPHRENIA

por Takeuchi, Hiroyoshi, Siu, Cynthia, Remington, Gary, Fervaha, Gagan, Foussias, George, Zipursky, Robert, Agid, Ofer
Publicado 2018

F60. INFLAMMATORY MARKERS AND COGNITIVE PERFORMANCE IN PATIENTS WITH SCHIZOPHRENIA TREATED WITH LURASIDONE

por Pikalov, Andrei, Miller, Brian, Siu, Cynthia, Tocco, Michael, Tsai, Joyce, Harvey, Philip, Loebel, Antony
Publicado 2018

Daytime sleepiness associated with lurasidone and quetiapine XR: results from a randomized double-blind, placebo-controlled trial in patients with schizophrenia

por Loebel, Antony D., Siu, Cynthia O., Cucchiaro, Josephine B., Pikalov, Andrei A., Harvey, Philip D.
Publicado 2013

Insight and subjective measures of quality of life in chronic schizophrenia

por Siu, Cynthia O., Harvey, Philip D., Agid, Ofer, Waye, Mary, Brambilla, Carla, Choi, Wing-Kit, Remington, Gary
Publicado 2015